Ampio Pharmaceuticals Spins-Off Sexual Dysfunction Business

Ampio Pharmaceuticals (NYSE MKT: AMPE ) today announced that it has spun off its sexual dysfunction business into a standalone company called Vyrix Pharmaceuticals, Inc. The new Company is expected to be funded through an initial public offering. Vyrix' assets will include Zertane and Zertane-ED, late stage men's health